Global mapping of RNA N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) in human subcutaneous and visceral adipose tissue reveals novel targets that correlate with clinical variables of obesity.

Biomark Res · 2025 · PMC12613671 · PMID 41225618

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

Due to the relatively low number of genes, only a few significant GO terms were identified in our GO term analysis, all showing borderline significance for enrichment (Table S11 ).

also in 7,017 other papers

nominally significantno p-value reported

Spearman correlation with p < 0.05 was considered as nominally significant.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Global mapping of RNA N&lt;sup&gt;6&lt;/sup&gt;-methyladenosine (m&lt;sup&gt;6&lt;/sup&gt;A) in human subcutaneous and visceral adipose tissue reveals novel targets that correlate with clinical variables of obesity.

The sentences

Global mapping of RNA N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) in human subcutaneous and visceral adipose tissue reveals novel targets that correlate with clinical variables of obesity.